Climb Bio CLYM
NASDAQ CLYM
$12.25 +0.51 (+4.34%)
As of: Nov 11, 2026 · 3:42 PM EST

Climb Bio (CLYM) Price to FCF (2024)

Updated

Climb Bio's (CLYM) Price to FCF stood at 3785.71 in Q2 2024.

Analysis

Climb Bio (CLYM) Price to FCF (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Climb Bio 939.56 Mn 340.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3,785.71
API Access

Climb Bio Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=CLYM&period=max&api_key=YOUR_API_KEY